T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
RLJ Lodging Trust
RLJ
$1.68B
| $69.1M | 0.01% |
2,321,502
+39,131
| +2% | +$1.19M |
|
727
Equinix
EQIX
$108B
| $68.7M | 0.01% |
270,459
-2,100
| -0.8% | -$536K |
|
728
WIX.com
WIX
$3.13B
| $68.1M | 0.01% |
2,883,335
+736,774
| +34% | +$16.8M |
|
729
Rollins
ROL
$17.4B
| $68M | 0.01% |
5,359,448
+3,926,817
| +274% | +$44.3M |
|
730
Alexandria Real Estate Equities
ARE
$8.29B
| $67.8M | 0.01% |
775,471
-174,395
| -18% | -$16.2M |
|
|
CCMP
731
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $67.5M | 0.01% |
1,433,866
-10,160
| -0.7% | -$485K |
|
732
Freeport-McMoran
FCX
$93.5B
| $67.4M | 0.01% |
3,617,331
+233,751
| +7% | +$4.83M |
|
|
SPTN
733
DELISTED
SpartanNash
SPTN
| $67.3M | 0.01% |
2,067,340
-350,050
| -14% | -$11.2M |
|
734
Lennar Class A
LEN
$20.9B
| $67.2M | 0.01% |
1,382,933
-81,264
| -6% | -$3.74M |
|
735
W.W. Grainger
GWW
$62.4B
| $66.9M | 0.01% |
282,702
-110,216
| -28% | -$26.7M |
|
736
SM Energy
SM
$8.01B
| $66.7M | 0.01% |
1,446,987
+74,785
| +5% | +$3.95M |
|
737
National Bank Holdings
NBHC
$1.94B
| $66.7M | 0.01% |
3,202,940
+118,640
| +4% | +$2.31M |
|
|
SONC
738
DELISTED
Sonic Corp
SONC
| $66.4M | 0.01% |
2,306,397
+3,775
| +0.2% | +$116K |
|
|
KNGT
739
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $66.4M | 0.01% |
2,482,952
-508,635
| -17% | -$13.6M |
|
740
Chesapeake Utilities
CPK
$3.26B
| $66.2M | 0.01% |
1,229,397
+11,402
| +0.9% | +$589K |
|
741
Archrock
AROC
$6.04B
| $66M | 0.01% |
2,020,379
-2,044,383
| -50% | -$69.1M |
|
|
ONCE
742
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $65.9M | 0.01% |
1,131,296
-73,230
| -6% | -$4.84M |
|
|
BFS
743
Saul Centers
BFS
$864M
| $65.3M | 0.01% |
1,328,310
+16,851
| +1% | +$877K |
|
744
Moog Inc Class A
MOG.A
$13.8B
| $65.1M | 0.01% |
921,337
-200
| -0% | -$14.2K |
|
|
MJN
745
DELISTED
Mead Johnson Nutrition Company
MJN
| $65M | 0.01% |
720,277
+206,510
| +40% | +$19.9M |
|
|
NILE
746
DELISTED
Blue Nile, Inc.
NILE
| $64.8M | 0.01% |
2,131,259
-5,200
| -0.2% | -$149K |
|
|
WAGE
747
DELISTED
WageWorks, Inc.
WAGE
| $64.4M | 0.01% |
1,592,595
-721,405
| -31% | -$33.6M |
|
748
Truist Financial
TFC
$64.9B
| $64.1M | 0.01% |
1,590,062
+96,440
| +6% | +$3.82M |
|
|
ESGR
749
DELISTED
Enstar Group
ESGR
| $64M | 0.01% |
413,168
-145,516
| -26% | -$21.7M |
|
|
HUB.B
750
DELISTED
HUBBELL INC CL-B
HUB.B
| $64M | 0.01% |
591,236
-154,262
| -21% | -$17M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.